Rationale: Indoor particulate matter is associated with worse chronic obstructive pulmonary disease (COPD) outcomes. It remains unknown whether reductions of indoor pollutants improve respiratory morbidity. Objectives: To determine whether placement of active portable high-efficiency particulate air cleaners can improve respiratory morbidity in former smokers. Methods: Eligible former smokers with moderate-to-severe COPD received active or sham portable high-efficiency particulate absolute air cleaners and were followed for 6 months in this blinded randomized controlled trial. The primary outcome was 6-month change in St. George's Respiratory Questionnaire (SGRQ). Secondary outcomes were exacerbation risk, respiratory symptoms, rescue medication use, and 6-minute-walk distance (6MWD). Intention-to-treat analysis included all subjects, and per-protocol analysis included adherent participants (greater than 80% use of air cleaner). Measurements and Main Results: A total of 116 participants were randomized, of which 84.5% completed the study. There was no statistically significant difference in total SGRQ score, but the active filter group had greater reduction in SGRQ symptom subscale (β, -7.7 [95% confidence interval (CI), -15.0 to -0.37]) and respiratory symptoms (Breathlessness, Cough, and Sputum Scale, β, -0.8 [95% CI, -1.5 to -0.1]); and lower rate of moderate exacerbations (incidence rate ratio, 0.32 [95% CI, 0.12-0.91]) and rescue medication use (incidence rate ratio, 0.54 [95% CI, 0.33-0.86]) compared with sham group (all P < 0.05). In per-protocol analysis, there was a statistically significant difference in primary outcome between the active filter versus sham group (SGRQ, β -4.76 [95% CI, -9.2 to -0.34]) and in moderate exacerbation risk, Breathlessness, Cough, and Sputum Scale, and 6MWD. Participants spending more time indoors were more likely to have treatment benefit. Conclusions: This is the first environmental intervention study conducted among former smokers with COPD showing potential health benefits of portable high-efficiency particulate absolute air cleaners, particularly among those with greater adherence and spending a greater time indoors.
Rationale: Indoor particulate matter is associated with worse chronic obstructive pulmonary disease (COPD) outcomes. It remains unknown whether reductions of indoor pollutants improve respiratory morbidity. Objectives: To determine whether placement of active portable high-efficiency particulate air cleaners can improve respiratory morbidity in former smokers. Methods: Eligible former smokers with moderate-to-severe COPD received active or sham portable high-efficiency particulate absolute air cleaners and were followed for 6 months in this blinded randomized controlled trial. The primary outcome was 6-month change in St. George's Respiratory Questionnaire (SGRQ). Secondary outcomes were exacerbation risk, respiratory symptoms, rescue medication use, and 6-minute-walk distance (6MWD). Intention-to-treat analysis included all subjects, and per-protocol analysis included adherent participants (greater than 80% use of air cleaner). Measurements and Main Results: A total of 116 participants were randomized, of which 84.5% completed the study. There was no statistically significant difference in total SGRQ score, but the active filter group had greater reduction in SGRQ symptom subscale (β, -7.7 [95% confidence interval (CI), -15.0 to -0.37]) and respiratory symptoms (Breathlessness, Cough, and Sputum Scale, β, -0.8 [95% CI, -1.5 to -0.1]); and lower rate of moderate exacerbations (incidence rate ratio, 0.32 [95% CI, 0.12-0.91]) and rescue medication use (incidence rate ratio, 0.54 [95% CI, 0.33-0.86]) compared with sham group (all P < 0.05). In per-protocol analysis, there was a statistically significant difference in primary outcome between the active filter versus sham group (SGRQ, β -4.76 [95% CI, -9.2 to -0.34]) and in moderate exacerbation risk, Breathlessness, Cough, and Sputum Scale, and 6MWD. Participants spending more time indoors were more likely to have treatment benefit. Conclusions: This is the first environmental intervention study conducted among former smokers with COPD showing potential health benefits of portable high-efficiency particulate absolute air cleaners, particularly among those with greater adherence and spending a greater time indoors.
Entities:
Keywords:
COPD; air filters; clinical trial; environment; particulate matter
Authors: Arlene M Butz; Elizabeth C Matsui; Patrick Breysse; Jean Curtin-Brosnan; Peyton Eggleston; Gregory Diette; D'Ann Williams; Jie Yuan; John T Bernert; Cynthia Rand Journal: Arch Pediatr Adolesc Med Date: 2011-08
Authors: Amy J H Kind; Steve Jencks; Jane Brock; Menggang Yu; Christie Bartels; William Ehlenbach; Caprice Greenberg; Maureen Smith Journal: Ann Intern Med Date: 2014-12-02 Impact factor: 25.391
Authors: Roger D Peng; Arlene M Butz; Amber J Hackstadt; D'Ann L Williams; Gregory B Diette; Patrick N Breysse; Elizabeth C Matsui Journal: J R Stat Soc Ser A Stat Soc Date: 2014-07-15 Impact factor: 2.483
Authors: Laura M Paulin; Amanda J Gassett; Neil E Alexis; Kipruto Kirwa; Richard E Kanner; Stephen Peters; Jerry A Krishnan; Robert Paine; Mark Dransfield; Prescott G Woodruff; Christopher B Cooper; R Graham Barr; Alejandro P Comellas; Cheryl S Pirozzi; MeiLan Han; Eric A Hoffman; Fernando J Martinez; Han Woo; Roger D Peng; Ashraf Fawzy; Nirupama Putcha; Patrick N Breysse; Joel D Kaufman; Nadia N Hansel Journal: JAMA Intern Med Date: 2020-01-01 Impact factor: 21.873
Authors: Nirupama Putcha; Milo A Puhan; M Bradley Drummond; MeiLan K Han; Elizabeth A Regan; Nicola A Hanania; Carlos H Martinez; Marilyn Foreman; Surya P Bhatt; Barry Make; Joe Ramsdell; Dawn L DeMeo; R Graham Barr; Stephen I Rennard; Fernando Martinez; Edwin K Silverman; James Crapo; Robert A Wise; Nadia N Hansel Journal: PLoS One Date: 2014-12-16 Impact factor: 3.240
Authors: Deepak A Kaji; Andrew J Belli; Meredith C McCormack; Elizabeth C Matsui; D'Ann L Williams; Laura Paulin; Nirupama Putcha; Roger D Peng; Gregory B Diette; Patrick N Breysse; Nadia N Hansel Journal: BMC Pulm Med Date: 2014-09-10 Impact factor: 3.317
Authors: Takudzwa Mkorombindo; John R Balmes; Adnan Custovic; Mark T Dransfield Journal: Am J Respir Crit Care Med Date: 2022-02-15 Impact factor: 21.405
Authors: Shuguang Leng; Maria A Picchi; Paula M Meek; Menghui Jiang; Samuel H Bayliss; Ting Zhai; Ruslan I Bayliyev; Yohannes Tesfaigzi; Matthew J Campen; Huining Kang; Yiliang Zhu; Qing Lan; Akshay Sood; Steven A Belinsky Journal: Respir Res Date: 2022-09-08